Diabetes and everolimus eluting bioresorbable poly-L-lactide vascular scaffolds for coronary artery disease: Dead-end or some path forward?

Catheter Cardiovasc Interv. 2021 Oct;98(4):721-722. doi: 10.1002/ccd.29900.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Absorbable Implants
  • Coronary Artery Disease* / diagnostic imaging
  • Coronary Artery Disease* / surgery
  • Diabetes Mellitus*
  • Everolimus / adverse effects
  • Humans
  • Polyesters
  • Treatment Outcome

Substances

  • Polyesters
  • poly(lactide)
  • Everolimus